Search results for: Health Policy and Regulation
Filter search results
International Comparisons of Medicines Prices: 2011 Indices
1 October 2012
Since 1996, in its yearly PPRS Report to Parliament, the Department of Health in England has published international price comparisons of branded medicines used in the primary care setting. OHE…
Access Mechanisms for Orphan Drugs: A Comparative Study of Selected European Countries
1 November 2009
This study compares pricing and reimbursement (P&R) policy for 43 orphan medicinal products (OMPs) across seven EU Member States: France, Germany, Italy, The Netherlands, Spain, Sweden and the UK. Examined…
European Medicines Pricing and Reimbursement: Now and the Future
1 January 2007
…and reimbursement policies in Germany: current and future trends; Pricing and reimbursement policies in UK: a current and future trends; Pricing and reimbursement policies in Italy: current and future trends;…
Pharmaceutical Prices: A continental view
1 April 1978
It has not normally been OHE policy to reprint articles which have previously been published elsewhere. However, it seemed desirable to make an exception for this paper by Dr Klaus…
The Doctor’s (Ethical and Economic) Dilemma
1 August 1996
…of benefits and burdens to everyone)’. On this relationship between evidence-based medicine and issues of cost effectiveness and rationing, Sackett is both thoughtful and thought provoking. He argues that he,…
How Much Should We Spend on the NHS?
1 July 2004
…Office of Health Economics, the King’s Fund and the Centre for Health Economics was held on 13 November 2002 to critically examine the assumptions, estimates and models underpinning the recommendations…
The WHO Technical Report on the Pricing of Cancer Medicines: Missing a central role for HTA and value assessment
1 April 2019
…demand side reforms that use new treatments efficiently and send the right signals to industry about the new cancer treatments (and associated health gains) that payers want to fund. The…
HTAi Asia Policy Forum Briefing Papers: Value and Affordability, Transferability, and Delivery of High Quality HTA for Decision Making
2 May 2017
…medical device companies with interest and expertise in Asia; invited experts; and the organisers, and are designed to promote in-depth, open and constructive exchange between these stakeholder groups. The OHE…
OHE Welcomes Patrick Holmes to the Board of Trustees
28 March 2022
…in New York and heads a team responsible for developing global health policy initiatives and evidence across a series of policy issues supporting Pfizer’s R&D-driven organization, including driving affordable patient…